Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Jennifer O'Sullivan
,
Imran Omerdeen
,
Bethan Psaila
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
British Journal of Haematology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis
by: Rithin Nedumannil, et al.
Published: (2025)
Primary myelofibrosis with increased haemoglobin concentration at presentation
by: Giovanni Barosi, et al.
Published: (2025)
Autoimmune myelofibrosis: A Mayo Clinic series of 22 patients
by: Naseema Gangat, et al.
Published: (2024)
Improved outcomes in primary myelofibrosis patients with increased haemoglobin concentration
by: Ivan Krecak, et al.
Published: (2025)
Interpretable machine learning model using peripheral blood for non‐invasive detection of moderate‐to‐severe myelofibrosis in JAK2 V617F ‐positive MPNs : A multicentre pilot proof‐of‐concept study
by: Zhuanghui Hao, et al.
Published: (2026)